Chimica Oggi – Chemistry Today Interview with Aslam Malik
A word with…Aslam Malik PhD, CEO SK pharmteco After the acquisition of Yposkesi that allowed SK pharmteco to enter
A word with…Aslam Malik PhD, CEO SK pharmteco After the acquisition of Yposkesi that allowed SK pharmteco to enter
SK Inc. to invest $350M through SK pharmteco. SK Inc. announced on January 9th that it has invested $350 million
In a recent interview with Japan Chemical Daily, Aslam Malik, CEO of SK pharmteco, shares the company’s growth in Cell
"*" indicates required fields